Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports termination of the INBRX-105 in combination with pembrolizumab across multiple solid tumors, including hea…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
A completed clinical trial evaluating disease burden and tumor biology in metastatic renal cell carcinoma using tumor cell free DNA.
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells [EARLY_Phase 1]
Early-phase clinical trial update for Anti-CD70-CAR-T Cell injection targeting CD70+ renal cell carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety and preliminary efficacy of meldonium in patients with metastatic renal cell carcinoma and…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy [NA]
A clinical trial update noting recruitment for a study evaluating telemonitoring to manage side effects in patients with melanoma, lung canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer [Phase 3]
A Phase 3 trial evaluating TQB2450 plus Anlotinib hydrochloride capsule versus Sunitinib in patients with advanced renal cell carcinoma; the…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Renal Cell Carcinoma Microenvironment Discovery Project
This update indicates the Renal Cell Carcinoma Microenvironment Discovery Project has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS) [Phase 4]
Phase 4 clinical trial evaluating whether contrast-enhanced ultrasound findings correlate with pathologic grade in renal masses; the study w…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC
A completed clinical trial evaluating whether inflammatory markers ICC and MCVL can predict response to nivolumab in metastatic renal cell c…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
This clinical trial update describes a study evaluating skin health and quality of life in patients receiving anti-PD-1/PD-L1/CTLA-4 inhibit…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Pfizer-sponsored study in the Hospital District of Southwest Finland has completed and describes the kidney cancer patient population, treat…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer completed a post-marketing drug-use investigation for temsirolimus in renal cell carcinoma. The trial results have been posted.
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors [Phase 1]
Describes a Phase 1 clinical trial of SPX-303, a bispecific antibody targeting LILRB2 and PD-L1, in patients with solid tumors, including he…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
Pfizer-sponsored STAR-TOR registry study update reports completion and posted results for a three-drug regimen of temsirolimus, sunitinib, a…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCC [Phase 2]
Phase 2 neoadjuvant trial of pembrolizumab plus lenvatinib in advanced renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients [Phase 1]
Phase 1 trial of the personalized neoantigen vaccine IVAC-RCC-001 added to standard-of-care checkpoint inhibitor therapy for advanced renal …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Pfizer-sponsored master protocol evaluating treatment patterns, medication adherence, and health and economic outcomes in renal cell carcino…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma [NA]
A prospective registry study evaluating stereotactic ablative radiotherapy (SABR) for oligometastatic renal cell carcinoma, currently not re…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating entinostat in combination with nivolumab and ipilimumab in previously treated renal cell carcinoma has been termi…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients [Phase 1, Phase 2]
Trial update describing a Phase 1/2 study of vorolanib in combination with cadonilimab for untreated advanced renal cell carcinoma, currentl…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Lateral Position [NA]
The document describes a recruiting clinical trial comparing robot-assisted laparoscopic partial nephrectomy via an extraperitoneal approach…
-
CLINICAL_TRIALS other · 2024-08-20Clinical Trial Update: A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer [Phase 1, Phase 2]
This entry describes a Phase I/II clinical trial of UCB4594 for multiple advanced solid tumors, including head and neck squamous cell carcin…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1]
RemeGen's RC198 is being evaluated in a Phase 1 study across locally advanced unresectable or metastatic solid tumors, including melanoma, u…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma [NA]
A clinical trial evaluating a ketogenic diet in patients receiving treatment for metastatic renal cell carcinoma has completed.